Pharmacokinetic Evaluation of the Relative Bioavailability of Three Paliperidone Extended Release (ER) Formulations With Different in Vitro Release Profiles, and Comparison to Paliperidone Immediate Release (IR), in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2009
At a glance
- Drugs Paliperidone (Primary)
- Indications Psychotic disorders
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 29 Jan 2009 Actual patient numbers (80) added as reported by ClinicalTrials.gov.
- 28 Nov 2008 New trial record.